原标题：GEM创下五年半新高，“抗流行病”概念重新回到最前沿，诞生了22倍的大牛市！
概要
[TheGEMrefreshedafive-and-a-half-yearhighTheconceptof”anti-epidemic”returnedtotheforefront22timesthebigbullstockwasborn!】TherecentstrongperformanceofChiNextmainlycomesfromtherapidriseofpharmaceuticalstocksFollowingyesterday’sperformanceofZhaoyanNewDrugandOpcombothexceededexpectationsleadingtheCXO(pharmaceuticaloutsourcing)andophthalmologysectorstorisecollectivelyInearlytradingtodaytheconceptof”anti-epidemic”tookontheriseunderthestimulusofnewsandthepharmaceuticalsectorshowedagoodroundofrisingpattern(ShanghaiSecuritiesNews)
In early trading today, the three major A-share stock indexes continued to advance by leaps and bounds.The Shanghai Composite IndexHit a new high this year,Growth Enterprise Market IndexSet a record high in the past 5 and a half years.
As of the noon close, the Shanghai Composite Index reported 3,629.61 points, an increase of 1.30%;Shenzhen Component IndexReported at 15505.29 points, an increase of 1.85%;Start a businessThe board index reported 3276.57 points, up 2.24%.
The concept of “anti-epidemic” rises
The recent strong performance of the GEM is mainly due to the rapid rise of pharmaceutical stocks.Following yesterdayZhaoyan New Drug、OpcomBothPerformanceExceeding expectations, leading CXO (medicalOutsourcing), after the collective promotion of the ophthalmology medical sector. In early trading today, the concept of “anti-epidemic” took on the rise under the stimulus of news, and the pharmaceutical sector showed a good round of rising pattern.
As of the noon close, the new crown pneumonia detection index rose 4.60%. In terms of individual stocks,Golden Field Medical、Mingde Bio、Xilong ScienceClosed the price limit,Cap Bio、Dean diagnosisThey rose by 13.90% and 11.67% respectively.
The early performance of the new coronary pneumonia detection plate
On the news, according to “Xinhua Viewpoint”WeiboReport: National Health Commission’s CDC Supervisor Wang Bin stated at the State Council’s joint prevention and control mechanism press conference on the 20th that township sampling and county testing should be implemented throughout the country, and testing agencies should give feedback within 12 hours after receiving samples Test results: If it is said that they must return home, the returnees need to have a negative nucleic acid test within 7 days before they can return. At the same time, after these returnees return, the local grassroots government must conduct grid management. At the same time, make preparations for isolation sites and testing capabilities so that in the event of an epidemic, they can respond quickly.
The provinces also issued personnel control measures accordingly.
The Jiangxi Provincial Epidemic Prevention and Control Headquarters issued Order No. 23: All personnel who have come (returned) to Jiangxi must hold a negative nucleic acid test within 7 days and report to their community (village group) or unit by themselves or their relatives or friends 24 hours before arriving in Jiangxi Report: After returning home, home health monitoring will be carried out for 14 days. During this period, there will be no gathering or flow, and nucleic acid testing will be carried out every 7 days.
HaveBrokeragemedicineteamToday’s follow-up report, I believe that the follow-up implementation of the policy may affect nucleic acid testingproductOf manufacturers provide tens of billions of new markets, and for testing service providers, they provide hundreds of billions of market increments.It is recommended to pay attention to the centralized procurement of related new crown testing productsWinning bidenterprise, And a third-party medical testing laboratory with a relatively complete national layout.
Intech MedicalSoaring 22 times in less than 13 months
In addition to testing companies, companies engaged in protective equipment have also benefited from the upgrade of epidemic prevention and control measures.
As a leader in the concept of “anti-epidemic”, protective glove companyIntech MedicalToday’s morning stock price hit a record high again. As of midday, it rose 4%, and the cumulative increase since the new year has reached 50.76%. If calculated since the beginning of last year,Intech MedicalThe stock price has risen by 2204% in less than 13 months.
Behind the soaring share price of Ingram Medical is the active pursuit of various institutions and foreign capital.
the companyDue toAdditional issuanceMatters and disclosed the top ten companies as of December 1 last yearshareholderList.It can be seen that 5 of the company’s latest top ten shareholders have appearedfund companySeat, and the Hong Kong Securities Clearing Company (that is, Northbound Capital) ranked third largest shareholder.
In the 2019 annual report, only one of the top ten shareholders of Intech Healthcare appearedfundCompany, and the company’s stock did not belong toShenzhen Stock ConnectSubject.
Ingram Medical’s list of top ten shareholders on December 1st last year
Guosheng Securities released Intech Medical stocks early this yearResearch report, Believes that the global supply of disposable gloves is in short supply, and the company is stabilizingSupply capacityIt has obvious advantages in the construction of new production capacity. It has achieved a leading advantage in the elimination of old production capacity and the breakout competition of new production capacity under the epidemic. The performance is high and the pace of becoming an international leader is expected to accelerate.The company is expected to return to the mother from 2020 to 2022Net profitThey were 7.06 billion yuan, 14.02 billion yuan, and 7.61 billion yuan, respectively.YoYAn increase of 3860.5%, 98.5%, -45.7%.
(Source: Shanghai Securities News)
(Editor in charge: DF398)
Solemnly declare: The purpose of this information released by Oriental Fortune.com is to spread more information and has nothing to do with this stand.